That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...

GSK is buying Rapt Therapeutics for $2.2 billion, the companies said Tuesday. Rapt stock rocketed.

The growing scourge of food allergies drove U.K. heavyweight pharmaceutical GSK to announce a $2.2 billion deal on Tuesday.

GSK plc agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and ...

GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...

How to Inject Semaglutide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ...

Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

The pandemic changed how Americans think about health — and who they trust to manage it. In the wreckage of lockdowns, millions turned away from doctors and toward influencers. Now, a growing number ...

Tricia Brock was directing Young Sherlock in Wales when she felt a familiar tickle in her throat. She was about to travel to Spain for the next leg of the project when along came the runny nose, sore ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...